Christopher Kuo,Krinio Giannikou,Nuoya Wang,Mikako Warren,Andrew Goodspeed,Nick Shillingford,Masanori Hayashi,Micha Sam Brickman Raredon,James F Amatruda
{"title":"空间分析确定肿瘤相关基质富集和MIF作为原发性尤文氏肉瘤的潜在免疫治疗靶点。","authors":"Christopher Kuo,Krinio Giannikou,Nuoya Wang,Mikako Warren,Andrew Goodspeed,Nick Shillingford,Masanori Hayashi,Micha Sam Brickman Raredon,James F Amatruda","doi":"10.1158/1078-0432.ccr-25-0635","DOIUrl":null,"url":null,"abstract":"PURPOSE\r\nThe Tumor Microenvironment (TME) has a vital role in cancer survival and progression, and may play roles in drug resistance and immune escape. To date, few studies have detailed the TME of Ewing sarcoma (EwS).\r\n\r\nEXPERIMENTAL DESIGN\r\nWe performed spatially resolved transcriptomics of primary treatment-naïve EwS tumor biopsies from patients with or without clinical metastasis, complemented by high-plex spatial proteomic analysis.\r\n\r\nRESULTS\r\nWe discovered greater stromal enrichment in localized EwS primary tumors compared to metastasis-associated EwS primary tumors. Through spatial ligand-receptor analysis, we show that the stromal enriched regions harbor unique extracellular matrix related cytokines, immune recruitment and proinflammatory microenvironmental signals, implying EwS stroma may play an anti-tumor role by acting as an immune recruitment center. All EwS tumors expressed pro-tumorigenic MIF-CD74 immune signaling connectivity, suggesting a potential immune-evasive mechanism.\r\n\r\nCONCLUSIONS\r\nIn addition to the immune recruitment role of tumor-associated stroma, our findings provide spatial insight into the TME of EwS and provide a rationale for the preclinical investigation of MIF as a potential target for Ewing sarcoma immunotherapy.","PeriodicalId":10279,"journal":{"name":"Clinical Cancer Research","volume":"88 1","pages":""},"PeriodicalIF":10.2000,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Spatial profiling identifies tumor-associated stroma enrichment and MIF as potential immunotherapy targets in primary Ewing sarcomas.\",\"authors\":\"Christopher Kuo,Krinio Giannikou,Nuoya Wang,Mikako Warren,Andrew Goodspeed,Nick Shillingford,Masanori Hayashi,Micha Sam Brickman Raredon,James F Amatruda\",\"doi\":\"10.1158/1078-0432.ccr-25-0635\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"PURPOSE\\r\\nThe Tumor Microenvironment (TME) has a vital role in cancer survival and progression, and may play roles in drug resistance and immune escape. To date, few studies have detailed the TME of Ewing sarcoma (EwS).\\r\\n\\r\\nEXPERIMENTAL DESIGN\\r\\nWe performed spatially resolved transcriptomics of primary treatment-naïve EwS tumor biopsies from patients with or without clinical metastasis, complemented by high-plex spatial proteomic analysis.\\r\\n\\r\\nRESULTS\\r\\nWe discovered greater stromal enrichment in localized EwS primary tumors compared to metastasis-associated EwS primary tumors. Through spatial ligand-receptor analysis, we show that the stromal enriched regions harbor unique extracellular matrix related cytokines, immune recruitment and proinflammatory microenvironmental signals, implying EwS stroma may play an anti-tumor role by acting as an immune recruitment center. All EwS tumors expressed pro-tumorigenic MIF-CD74 immune signaling connectivity, suggesting a potential immune-evasive mechanism.\\r\\n\\r\\nCONCLUSIONS\\r\\nIn addition to the immune recruitment role of tumor-associated stroma, our findings provide spatial insight into the TME of EwS and provide a rationale for the preclinical investigation of MIF as a potential target for Ewing sarcoma immunotherapy.\",\"PeriodicalId\":10279,\"journal\":{\"name\":\"Clinical Cancer Research\",\"volume\":\"88 1\",\"pages\":\"\"},\"PeriodicalIF\":10.2000,\"publicationDate\":\"2025-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Cancer Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1158/1078-0432.ccr-25-0635\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/1078-0432.ccr-25-0635","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
Spatial profiling identifies tumor-associated stroma enrichment and MIF as potential immunotherapy targets in primary Ewing sarcomas.
PURPOSE
The Tumor Microenvironment (TME) has a vital role in cancer survival and progression, and may play roles in drug resistance and immune escape. To date, few studies have detailed the TME of Ewing sarcoma (EwS).
EXPERIMENTAL DESIGN
We performed spatially resolved transcriptomics of primary treatment-naïve EwS tumor biopsies from patients with or without clinical metastasis, complemented by high-plex spatial proteomic analysis.
RESULTS
We discovered greater stromal enrichment in localized EwS primary tumors compared to metastasis-associated EwS primary tumors. Through spatial ligand-receptor analysis, we show that the stromal enriched regions harbor unique extracellular matrix related cytokines, immune recruitment and proinflammatory microenvironmental signals, implying EwS stroma may play an anti-tumor role by acting as an immune recruitment center. All EwS tumors expressed pro-tumorigenic MIF-CD74 immune signaling connectivity, suggesting a potential immune-evasive mechanism.
CONCLUSIONS
In addition to the immune recruitment role of tumor-associated stroma, our findings provide spatial insight into the TME of EwS and provide a rationale for the preclinical investigation of MIF as a potential target for Ewing sarcoma immunotherapy.
期刊介绍:
Clinical Cancer Research is a journal focusing on groundbreaking research in cancer, specifically in the areas where the laboratory and the clinic intersect. Our primary interest lies in clinical trials that investigate novel treatments, accompanied by research on pharmacology, molecular alterations, and biomarkers that can predict response or resistance to these treatments. Furthermore, we prioritize laboratory and animal studies that explore new drugs and targeted agents with the potential to advance to clinical trials. We also encourage research on targetable mechanisms of cancer development, progression, and metastasis.